We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

58 hedge funds and large institutions have $161M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 4

5% more capital invested

Capital invested by funds: $154M → $161M (+$7.5M)

0% more funds holding

Funds holding: 58 → 58 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
58
Holders Change
–
Holders Change %
0%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
18
Reduced
4
Closed
7
Calls
$101K
Puts
–
Net Calls
+$101K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$4.2M
2
FTCM
First Trust Capital Management
Illinois
+$1.12M
3
MF
Magnetar Financial
Illinois
+$1.05M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.01M
5
AA
AQR Arbitrage
Connecticut
+$987K

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$4.01M
2
JP Morgan Chase
JP Morgan Chase
New York
-$1M
3
ECU
Eisler Capital (UK)
United Kingdom
-$803K
4
KC
Kryger Capital
United Kingdom
-$421K
5
UOC
UBS O'Connor
Illinois
-$384K
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
26
Picton Mahoney Asset Management
Ontario, Canada
$2.05M +$35.9K +3,574 +2%
Goldman Sachs
27
Goldman Sachs
New York
$2.04M – – –
AIMCA
28
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.01M – – –
WA
29
Whitebox Advisors
Minnesota
$2.01M – – –
CCM
30
Context Capital Management
California
$1.36M – – –
CH
31
CVI Holdings
Delaware
$1.21M – – –
SV
32
Starboard Value
New York
$1.08M – – –
Walleye Capital
33
Walleye Capital
New York
$1.04M – – –
OCM
34
Oaktree Capital Management
California
$1.01M – – –
DKCM
35
Davidson Kempner Capital Management
New York
$1.01M – – –
WAM
36
Wolverine Asset Management
Illinois
$798K -$42.5K -4,232 -5%
Walleye Trading
37
Walleye Trading
New York
$634K – – –
BCM
38
Basso Capital Management
Connecticut
$557K +$555K +55,288 New
CC
39
Centiva Capital
New York
$506K +$67.3K +6,700 +15%
Citigroup
40
Citigroup
New York
$504K – – –
LA
41
Linden Advisors
New York
$452K – – –
DAM
42
DLD Asset Management
New York
$436K – – –
BFM
43
Boothbay Fund Management
New York
$330K +$7.08K +705 +2%
GCL
44
Glazer Capital LLC
New York
$326K -$11.7K -1,162 -3%
ASM
45
ATW SPAC Management
New York
$317K – – –
LCM
46
Lynwood Capital Management
Ontario, Canada
$317K – – –
SAMU
47
SONA Asset Management (US)
New York
$302K – – –
COPPSERS
48
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$252K – – –
DCM
49
Dupont Capital Management
Delaware
$252K – – –
PP
50
Paloma Partners
Connecticut
$201K – – –
1
2
3

IQMD Hedge Fund Activity: Q3 2022 in Review

58 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q3 2022, worth a combined $161M — up 4.9% from $154M a quarter earlier.

Fund positioning in IQMD was balanced in Q3 2022: 7 funds opened new positions, 7 closed out, 18 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, adding an estimated $4.2M. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $4.01M sold.

  • 58 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $161M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q3 2022, up 4.9% quarter-over-quarter.
  • 7 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q3 2022 and 7 closed out, a net change of 0 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q3 2022 was Millennium Management, an estimated $4.2M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q3 2022 was Cantor Fitzgerald, an estimated $4.01M sold.

Based on aggregated 13F filings for Q3 2022.